News tagged with placebo
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Neuroscience
18 hours ago |
4.9 / 5 (14) |
0
|
Researchers use magnetic pulses to brain to reduce overly optimistic tendencies
(Medical Xpress)—Scientists have known for many years that human beings, as a general rule, are an overly optimistic bunch. We close our eyes to statistics suggesting our eating habits may be killing us, ...
Neuroscience
Sep 25, 2012 |
4.3 / 5 (3) |
4
|
Placebo response, pain experience occur at nonconscious level: study
With the discovery that the unconscious mind plays a key role in the placebo effect, researchers have identified a novel mechanism that helps explain the power of placebos and nocebos.
Medical research
Sep 10, 2012 |
5 / 5 (4) |
1
Targeting inflammation to treat depression
Researchers at Emory University have found that a medication that inhibits inflammation may offer new hope for people with difficult-to-treat depression. The study was published Sept. 3 in the online version of Archives of ...
Psychology & Psychiatry
Sep 03, 2012 |
4.9 / 5 (18) |
3
|
FDA approves use of electronic chips in medications
(Medical Xpress) -- The Food and Drug Administration in the United States has approved a request by Proteus Digital Health to allow for the inclusion of tiny digestible microchips into medicines to assist ...
Medications
Aug 01, 2012 |
3.8 / 5 (5) |
3
|
Study: Antibiotics ineffective for most sinus infections
Antibiotics that doctors typically prescribe for sinus infections do not reduce symptoms any better than an inactive placebo, according to investigators at Washington University School of Medicine in St. Louis.
Diseases, Conditions, Syndromes
Feb 14, 2012 |
4.8 / 5 (6) |
4
|
Meningitis B type vaccine available soon
(Medical Xpress) -- Researchers in Chile have successfully tested a vaccine against meningococcus B, a strain of bacteria that causes meningococcal diseases, including one of the commonest forms of meningitis, a disease in ...
Medications
Jan 20, 2012 |
4.7 / 5 (6) |
0
|
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
HIV & AIDS
May 19, 2013 |
5 / 5 (1) |
0
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
Psychology & Psychiatry
May 19, 2013 |
4.9 / 5 (7) |
1
|
Palivizumab cuts number of days of wheezing in preemies
(HealthDay)—Many pre-term babies suffer recurrent episodes of wheezing. Now, researchers say a common infection is a likely culprit and they may be able to prevent the breathing problems.
Diseases, Conditions, Syndromes
May 09, 2013 |
not rated yet |
0
|
Minocycline, an antibiotic, improves behavior for children with fragile X syndrome
Minocycline, an older, broad-spectrum antibiotic in the tetracycline family, provides meaningful improvements as a therapeutic for children with fragile X syndrome, a study by researchers at the UC Davis MIND Institute has ...
Pediatrics
Apr 08, 2013 |
5 / 5 (2) |
0
|
Antibiotic may provide benefit for treatment of respiratory disorder
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a ...
Diseases, Conditions, Syndromes
Mar 26, 2013 |
not rated yet |
0
|
New drugs may improve quality of life for people with Parkinson's disease
Three studies released today present possible positive news for people with Parkinson's disease. The studies, which will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, ...
Parkinson's & Movement disorders
Mar 14, 2013 |
3.5 / 5 (2) |
0
|
Study shows anemia drug does not improve health of anemic heart failure patients
Researchers from Cleveland Clinic and Sweden-based Sahlgrenska University Hospital have found that a commonly used drug to treat anemia in heart failure patients –darbepoetin alfa – does not improve patients' health, ...
Cardiology
Mar 11, 2013 |
not rated yet |
0
|
Niacin therapy unhelpful, occasionally harmful, study says
A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.
Cardiology
Mar 09, 2013 |
4 / 5 (1) |
0
Placebo
A placebo is a sham medical intervention. In one common placebo procedure, a patient is given an inert sugar pill, told that it may improve his/her condition, but not told that it is in fact inert. Such an intervention may cause the patient to believe the treatment will change his/her condition; and this belief does indeed sometimes have a therapeutic effect, causing the patient's condition to improve. This phenomenon is known as the placebo effect.
Placebos are widely used in medicine, and the placebo effect is a pervasive phenomenon; in fact, it is part of the response to any active medication. However, the deceptive nature of the placebo creates tension between the Hippocratic Oath and the honesty of the doctor-patient relationship. The placebo effect points to the importance of perception and the brain's role in physical health.
Since the publication of Henry K. Beecher's The Powerful Placebo in 1955 the phenomenon has been considered to have clinically important effects. This view was notably challenged when in 2001 a systematic review of clinical trials concluded that there was no evidence of clinically important effects, except perhaps in the treatment of pain and continuous subjective outcomes. The article received a flurry of criticism, but the authors later published a Cochrane review with similar conclusions. Most studies have attributed the difference from baseline till the end of the trial to a placebo effect, but the reviewers examined studies which had both placebo and untreated groups in order to distinguish the placebo effect from the natural progression of the disease.
For more information about Placebo, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.